Ethyl 5-bromo-4-nitrothiophene-2-carboxylate, 95+%, 250mg

1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole-6-carboxylic acid, 97%, 250mg

2H-pyrido[1,2-a]pyrimidine-2,4(3H)-dione, 100mg

4-tert-Butyl-3-methoxybenzoic acid, 97.0%, 25g

4-(Naphthalen-1-yl)-3,5-diphenyl-4H-1,2,4-triazole, 95.0%, 250mg

2-(2-Naphthyl)-2-propanol, 97.0%, 2.5g

1-(Tert-butyl) 4-methyl 4-(((benzyloxy)carbonyl)amino)piperidine-1,4-dicarboxylate, 95%, 250mg

3,3''-Difluoro-5'-(3-fluoro-4-formylphenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarbaldehyde, 97%, 1g

Methyl 2,6-dimethylpyrimidine-4-carboxylate, 98%, 5g

Iode, min 99,8 %, pa, ACS, resublimé, 100 g, emballage verre

Stachyose Hydrate>98.0%(HPLC)1g

6-Chloro-3-iodo-1H-pyrrolo[3,2-c]pyridine, 95.0%, 1g

Ethyl (S)-(-)-1-Ethyl-2-pyrrolidinecarboxylate>98.0%(GC)(T)5g